| Kids First Therapy, Llc | |
|
1102 7th St S, Fargo, ND 58103-2712 | |
| (701) 866-9529 | |
| Not Available |
| Full Name | Kids First Therapy, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 1102 7th St S, Fargo, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023416534 | NPI | - | NPPES |
| 1861690752 | Other | BLUE CROSS AND BLUE SHIELD | |
| 1861690752 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 955 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kids First Therapy, Llc 1102 7th St S, Fargo, ND 58103-2712 Ph: (701) 866-9529 | Kids First Therapy, Llc 1102 7th St S, Fargo, ND 58103-2712 Ph: (701) 866-9529 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Merck, has signed a worldwide research and development agreement with sanofi-aventis U.S. Inc., under which Merck Serono and sanofi-aventis U.S. Inc. will collaboratively investigate novel experimental combinations of agents that could block specific pathways in cancer cells. This collaboration could deliver novel targeted oncology treatments with high therapeutic potential.
In a new analysis of SARS-CoV-2, the virus that causes COVID-19, test results for nearly 38,000 people has found a positivity rate among Latinx populations about three times higher than for any other racial and ethnic group.
Gerontology students at University of Southern California had an opportunity to "become senior citizens" on Friday thanks to Trading Ages(TM), an interactive senior sensitivity training program sponsored by SCAN Health Plan.
Anavex Life Sciences Corp. ("Anavex") (OTCBB: AVXL) has announced that its clinical trial application (CTA) for ANAVEX 2-73, the company's lead compound for Alzheimer's disease, has been approved by the German regulatory health authority, BfArM. The Phase I trial of ANAVEX 2-73, which includes testing in healthy human volunteers, will commence immediately. In this Phase I program Anavex will assess the safety, maximally tolerated dose, pharmacokinetics and pharmacodynamics of ANAVEX 2-73.
› Verified 2 days ago
Mrs. Jill S Erickson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1727 South 16th Street, Fargo, ND 58103 Phone: 701-446-4800 | |
Katherine Wilson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2846 Brandt Dr S, Fargo, ND 58104 Phone: 701-232-2340 Fax: 701-232-2330 | |
Sarah Hoepfner, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-6970 Fax: 701-234-7391 | |
Nancy Knowlton, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3001 11th Ave S, Beyond Boundaries Speech-language, Fargo, ND 58103 Phone: 701-356-0062 Fax: 701-356-5412 | |
Kayla Marie Flach, MSLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 4500 36th Ave S Ste 200, Fargo, ND 58104 Phone: 701-532-1507 Fax: 701-532-1529 | |
Sydney M Honek, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4152 30th Ave S, Fargo, ND 58104 Phone: 701-551-1750 |